GBCS Research | Milton Maxwell

GBCS

Selectis Health, Inc.

1.9500

+0.0000+0%

Dec 16, 4:00:00 PM EST

Upcoming Earnings

Report date

≈ -/-

Earnings Call Transcripts

This Quarter (Q4 '25)

No earnings call transcript available yet

Last Quarter (Q3 '25)

No earnings call transcript available

Key Stats

Market Cap

5.98M

P/E (TTM)

Basic EPS (TTM)

-0.28

Dividend Yield

Recent Filings

8-K

12/9/25Dec 9, 2025

10-Q

11/14/25Nov 14, 2025

10-Q

Q2 FY2025 results

8/14/25Aug 14, 2025

Selectis Health posted Q2 revenue of $10.4M, up 9% y/y from $9.6M, driven by 11% higher healthcare revenue from Medicaid rate hikes in Georgia and Oklahoma facilities, while rental revenue vanished after last year's Archway sale. Operating loss narrowed to $450K from $764K y/y, thanks to lower G&A and depreciation, yet expenses climbed 5% on inflation-fueled operating costs. Net loss hit $308K, or $(0.10) per share on 3.07M diluted shares, versus a $794K profit last year boosted by a one-off asset gain; the gap stems from absent gains and steady interest. Cash stood at $560K with $772K restricted, supporting $958K operating cash flow for H1, but $32M debt looms with covenant breaches on two loans. A pending Georgia facility sale fell through in July. Ongoing litigation risks patient care claims.

8-K

Deal termination disrupts sale

7/16/25Jul 16, 2025

Selectis Health's deal to sell its Georgia subsidiaries collapsed on July 13, 2025, when the buyer terminated the Purchase and Sale Agreement and Operations Transfer Agreement without closing. The agreements, announced February 7, 2025, now leave the company eyeing legal remedies. Deal busts sting. No financial impacts disclosed yet.

8-K

Stock upgrades to OTCQB

6/20/25Jun 20, 2025

Selectis Health's common stock gained approval for upgraded quotation on the OTCQB from OTC Markets Group on June 20, 2025, with trading under ticker GBCS starting June 23. This move to a higher tier boosts visibility and liquidity for the emerging growth company. Yet trading begins Monday.

About

Selectis Health, Inc (Selectis or we or the Company) owns and operates, through wholly-owned subsidiaries Assisted Living Facilities, Independent Living Facilities, and Skilled Nursing Facilities across the South and Southeastern portions of the US. The Company acquires, develops, leases and manages healthcare real estate and provides healthcare operations through our wholly-owned subsidiaries. Our portfolio is comprised of investments in the following healthcare operations: (i) senior housing (including independent and assisted living) and (ii) post-acute/skilled nursing. We will make investments within our healthcare operations using the following six investment products: (i) direct ownership of properties, (ii) debt investments, (iii) developments and redevelopments, (iv) investment management, (v) the Housing and Economic Recovery Act of 2008 (RIDEA), which represents investments in senior housing operations utilizing the structure permitted by RIDEA and (vi) owning healthcare operations.

CEO

Mr. Adam Desmond

IPO

10/26/2004

Website

https://www.selectis.com

Employees

616

Sector

Healthcare

Industry

Medical Care Facilities